Purpose: To establish a consensus in relation to case selection, conduct of therapy, and
outcomes that are associated with focal therapy for men with localized prostate cancer …

PURPOSE: Based on contemporary epidemiological and pathological characteristics of
prostate cancer we explain the rationale for and concerns about focal therapy for low risk …

CONTEXT: A significant proportion of patients diagnosed with prostate cancer have well-
differentiated, low-volume tumors at minimal risk of impacting their quality of life or longevity …

Focal ablative therapy may be reasonable for some patients with prostate cancer; selection
factors include a variety of clinical and pathologic factors in combination with informed …

Background Focal therapy as a treatment option for localized prostate cancer (PCa) is an
increasingly popular and rapidly evolving field. Objective To gather expert opinion on patient …

BACKGROUND: Focal therapy (FT) for prostate cancer (PCa) seems to be part of a natural
evolution in the quest to improve the management of early organ-confined disease …

Context The incidence of localised prostate cancer is increasing worldwide. In light of recent
evidence, current, radical, whole-gland treatments for organ-confined disease have being …

Background Focal therapy has been introduced for the treatment of localised prostate
cancer (PCa). To provide the necessary data for consistent assessment, all focal therapy …

Radical treatment of localised prostate cancer is recognised to be an unnecessary
intervention or overtreatment in many men. Consequently, there has been a rapid uptake in …

Prostate cancer focal therapy is an attractive option for well-selected patients because of its
low complication profile; however, long-term oncologic outcome is still lacking and early …